WP
PMN icon

Woodline Partners’s ProMIS Neurosciences PMN Stock Holding History

Woodline Partners’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.82M Buy
441,911
+46,616
+12% +$506K 0.02% 653
2026
Q1 		$5.02M Buy
+395,295
New +$5.89M 0.02% 663

Other funds holding PMN

JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Woodline Partners's PMN Position: Q2 2026 in Review

Woodline Partners increased its ProMIS Neurosciences (PMN) stake by 12% in Q2 2026, buying an estimated $506K and bringing the position to 441,911 shares worth $5.82M. The position accounts for 0.02% of the portfolio, ranked #653.

Woodline Partners first reported a position in PMN in Q1 2026 and has held it in 2 quarters since. 27 funds tracked by Wall St. Rank hold PMN as of Q2 2026.

  • Woodline Partners held 441,911 shares of ProMIS Neurosciences worth $5.82M as of Q2 2026.
  • Woodline Partners bought 46,616 ProMIS Neurosciences shares in Q2 2026, an estimated $506K.
  • ProMIS Neurosciences made up 0.02% of Woodline Partners's portfolio in Q2 2026, its #653 holding.
  • Woodline Partners first reported a position in ProMIS Neurosciences in Q1 2026 and has held it in 2 quarters since.
  • 27 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.